Literature DB >> 28656715

Modified Lung Ultrasonographic Technique for Evaluation of Idiopathic Pulmonary Fibrosis: Lateral Decubitus Position.

Evangelia E Vassalou1, Maria Raissaki1, Eleftherios Magkanas2, Katerina M Antoniou3, Apostolos H Karantanas1.   

Abstract

OBJECTIVES: To compare lung ultrasonography (US) in the sitting or supine positions and the lateral decubitus position, with regard to the feasibility, duration, patient convenience, and assessment of B-lines, in patients with idiopathic pulmonary fibrosis.
METHODS: Twenty consecutive patients with idiopathic pulmonary fibrosis were prospectively enrolled. Lung US included scanning of 56 intercostal spaces. Each patient was examined twice by 2 protocols. During protocol 1, patients were examined in the supine and sitting positions for the anterior and dorsal chest, respectively. During protocol 2, patients were examined in the left lateral decubitus position for the evaluation of the right hemithorax and the reverse. Total, anterior, and posterior US scores resulted from the sum of B-lines at the whole, anterior, and posterior chest, respectively. High-resolution computed tomography (CT) was considered the reference standard. The duration of each protocol was recorded. Patients were questioned about which protocol they preferred.
RESULTS: There was no difference regarding feasibility between the protocols. A significant correlation was found between total US scores for both protocols and high-resolution CT findings (P < .0001), with protocol 2 showing a slightly higher correlation. A positive correlation was found between the protocols regarding total, anterior, and posterior US scores (P < .0001). The mean duration of protocol 2 was less than that of protocol 1 (P < .005). Nineteen patients (95%) reported a preference for protocol 2.
CONCLUSIONS: Lung US in the lateral decubitus position seems to be faster and more convenient. There appears to be no difference regarding feasibility and the number of B-lines, whereas it shows slightly higher correlation with high-resolution CT, compared with the sitting or supine positions in patients with idiopathic pulmonary fibrosis.
© 2017 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  B-lines; decubitus position; idiopathic pulmonary fibrosis; lung; lung ultrasonography

Mesh:

Year:  2017        PMID: 28656715     DOI: 10.1002/jum.14297

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  5 in total

1.  Assessment of Interstitial Lung Disease Using Lung Ultrasound Surface Wave Elastography: A Novel Technique With Clinicoradiologic Correlates.

Authors:  Ryan Clay; Brian J Bartholmai; Boran Zhou; Ronald Karwoski; Tobias Peikert; Thomas Osborn; Srinivasan Rajagopalan; Sanjay Kalra; Xiaoming Zhang
Journal:  J Thorac Imaging       Date:  2019-09       Impact factor: 3.000

2.  A simplified lung ultrasound for the diagnosis of interstitial lung disease in connective tissue disease: a meta-analysis.

Authors:  Hai Qin Xie; Wei Wei Zhang; De Sheng Sun; Xiang Mei Chen; Shu Fang Yuan; Zheng Hua Gong; Li Liu
Journal:  Arthritis Res Ther       Date:  2019-04-11       Impact factor: 5.156

3.  ThOracic Ultrasound in Idiopathic Pulmonary Fibrosis Evolution (TOUPIE): research protocol of a multicentric prospective study.

Authors:  Sylvie Legué; Sylvain Marchand-Adam; Laurent Plantier; Betsega Assefa Bayeh; Hugues Morel; Gilles Mangiapan; Thomas Flament
Journal:  BMJ Open       Date:  2021-03-25       Impact factor: 2.692

4.  Utility of lung ultrasound to identify interstitial lung disease: An observational study based on the STROBE guidelines.

Authors:  Jun-Hong Yan; Lei Pan; Yan-Bing Gao; Guang-He Cui; Yue-Heng Wang
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

Review 5.  Proposed Lung Ultrasound Protocol During the COVID-19 Outbreak.

Authors:  Evangelia E Vassalou; Apostolos H Karantanas; Katerina M Antoniou
Journal:  J Ultrasound Med       Date:  2020-08-06       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.